Intravenous Immunoglobulin (IVIg) Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL INTRAVENOUS IMMUNOGLOBULIN (IVIG) INDUSTRY

2.1 Summary about Intravenous Immunoglobulin (IVIg) Industry

2.2 Intravenous Immunoglobulin (IVIg) Market Trends

2.2.1 Intravenous Immunoglobulin (IVIg) Production & Consumption Trends

2.2.2 Intravenous Immunoglobulin (IVIg) Demand Structure Trends

2.3 Intravenous Immunoglobulin (IVIg) Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 IVIg Liquid

4.2.2 IVIg Powder

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Immunodeficiency

4.3.2 Autoimmune Disease

4.3.3 Acute Infection

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 IVIg Liquid

5.2.2 IVIg Powder

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Immunodeficiency

5.3.2 Autoimmune Disease

5.3.3 Acute Infection

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 IVIg Liquid

6.2.2 IVIg Powder

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Immunodeficiency

6.3.2 Autoimmune Disease

6.3.3 Acute Infection

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 IVIg Liquid

7.2.2 IVIg Powder

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Immunodeficiency

7.3.2 Autoimmune Disease

7.3.3 Acute Infection

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 IVIg Liquid

8.2.2 IVIg Powder

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Immunodeficiency

8.3.2 Autoimmune Disease

8.3.3 Acute Infection

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 IVIg Liquid

9.2.2 IVIg Powder

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Immunodeficiency

9.3.2 Autoimmune Disease

9.3.3 Acute Infection

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Baxter

10.1.2 Grifols

10.1.3 CSL

10.1.4 Octapharma

10.1.5 Biotest

10.1.6 Kedrion

10.1.7 Hualan Bio

10.1.8 CNBG

10.1.9 Shanghai RAAS

10.1.10 CBPO

10.1.11 LFB Group

10.1.12 BPL

10.1.13 Sichuan Yuanda Shuyang

10.2 Intravenous Immunoglobulin (IVIg) Sales Date of Major Players (2017-2020e)

10.2.1 Baxter

10.2.2 Grifols

10.2.3 CSL

10.2.4 Octapharma

10.2.5 Biotest

10.2.6 Kedrion

10.2.7 Hualan Bio

10.2.8 CNBG

10.2.9 Shanghai RAAS

10.2.10 CBPO

10.2.11 LFB Group

10.2.12 BPL

10.2.13 Sichuan Yuanda Shuyang

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

1.Table Intravenous Immunoglobulin (IVIg) Product Type Overview

2.Table Intravenous Immunoglobulin (IVIg) Product Type Market Share List

3.Table Intravenous Immunoglobulin (IVIg) Product Type of Major Players

4.Table Brief Introduction of Baxter

5.Table Brief Introduction of Grifols

6.Table Brief Introduction of CSL

7.Table Brief Introduction of Octapharma

8.Table Brief Introduction of Biotest

9.Table Brief Introduction of Kedrion

10.Table Brief Introduction of Hualan Bio

11.Table Brief Introduction of CNBG

12.Table Brief Introduction of Shanghai RAAS

13.Table Brief Introduction of CBPO

14.Table Brief Introduction of LFB Group

15.Table Brief Introduction of BPL

16.Table Brief Introduction of Sichuan Yuanda Shuyang

17.Table Products & Services of Baxter

18.Table Products & Services of Grifols

19.Table Products & Services of CSL

20.Table Products & Services of Octapharma

21.Table Products & Services of Biotest

22.Table Products & Services of Kedrion

23.Table Products & Services of Hualan Bio

24.Table Products & Services of CNBG

25.Table Products & Services of Shanghai RAAS

26.Table Products & Services of CBPO

27.Table Products & Services of LFB Group

28.Table Products & Services of BPL

29.Table Products & Services of Sichuan Yuanda Shuyang

30.Table Market Distribution of Major Players

31.Table Global Major Players Sales Revenue (Million USD) 2017-2020e

32.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

33.Table Global Intravenous Immunoglobulin (IVIg) Market Forecast (Million USD) by Region 2021f-2026f

34.Table Global Intravenous Immunoglobulin (IVIg) Market Forecast (Million USD) Share by Region 2021f-2026f

35.Table Global Intravenous Immunoglobulin (IVIg) Market Forecast (Million USD) by Demand 2021f-2026f

36.Table Global Intravenous Immunoglobulin (IVIg) Market Forecast (Million USD) Share by Demand 2021f-2026f